<?xml version="1.0" encoding="UTF-8"?>
<p>Beside the antiviral effects of IFNs, the potential role of IFN β-1a in improving ARDS complications was proposed. Expression of CD-73 proteins in lung cells and decrease in vascular leakage in ARDS and subsequent mortality were reported following treatment with intravenous IFN β-1a (
 <xref rid="B15" ref-type="bibr">15</xref>). However, the results were not repeated in the next, larger trial (
 <xref rid="B16" ref-type="bibr">16</xref>). This may be related to the extensive use of glucocorticoids in the latter trial that can interfere with the effect of IFN. The antagonist effects of corticosteroids are considerable (
 <xref rid="B30" ref-type="bibr">30</xref>).
</p>
